2015
DOI: 10.1016/j.neuron.2015.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Enkephalin Disinhibits Mu Opioid Receptor-Rich Striatal Patches via Delta Opioid Receptors

Abstract: SUMMARY Opioid neuropeptides and their receptors are evolutionarily conserved neuromodulatory systems that profoundly influence behavior. In dorsal striatum, which expresses the endogenous opioid enkephalin, patches (or striosomes) are limbic-associated subcompartments enriched in mu opioid receptors. The functional implications of opioid signaling in dorsal striatum and the circuit elements in patches regulated by enkephalin are unclear. Here, we examined how patch output is modulated by enkephalin and identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
104
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 95 publications
(114 citation statements)
references
References 52 publications
(71 reference statements)
10
104
0
Order By: Relevance
“…Matrix-Cre mice contained both direct (53.4 ± 3.9%) and indirect pathway (39.9 ± 3.9 %) neurons. In contrast, patch-Cre mice were predominantly D1 expressing (83.2 ± 1.9 %; t 3 = 9.36, p = 0.0026), matching previous reports (Gerfen and Young, 1988; Besson et al, 1990; Fujiyama et al, 2011; Banghart et al, 2015). Patch and exo-patch SPNs were found to have similar distributions of D1 (Figure S2; patch: 80.3 ± 1.8%; exo-patch: 80.7 ± 2.1%; paired sample t-test; t 1 = 0.94, p = 0.52) and D2 SPNs (patch: 14.7 ± 7.1%; exo-patch: 10.1 ± 2.4%; paired sample t-test; t 2 = 0.91, p = 0.46).…”
Section: Resultssupporting
confidence: 88%
See 3 more Smart Citations
“…Matrix-Cre mice contained both direct (53.4 ± 3.9%) and indirect pathway (39.9 ± 3.9 %) neurons. In contrast, patch-Cre mice were predominantly D1 expressing (83.2 ± 1.9 %; t 3 = 9.36, p = 0.0026), matching previous reports (Gerfen and Young, 1988; Besson et al, 1990; Fujiyama et al, 2011; Banghart et al, 2015). Patch and exo-patch SPNs were found to have similar distributions of D1 (Figure S2; patch: 80.3 ± 1.8%; exo-patch: 80.7 ± 2.1%; paired sample t-test; t 1 = 0.94, p = 0.52) and D2 SPNs (patch: 14.7 ± 7.1%; exo-patch: 10.1 ± 2.4%; paired sample t-test; t 2 = 0.91, p = 0.46).…”
Section: Resultssupporting
confidence: 88%
“…We have broadened the definition of patches to include “exo-patch” SPNs, which are located in the matrix but are characteristically more similar to patch SPNs. Specifically, patch and exo-patch groups are D1-receptor dominant, as previously shown for patches (Banghart et al, 2015), compared to matrix SPNs. Additionally, exo-patch SPNs appear in the expression profile of multiple patch-enriched genes (see Table 1 in Crittenden and Graybiel, 2011 for list of genes).…”
Section: Discussionsupporting
confidence: 66%
See 2 more Smart Citations
“…First identified by the expression patterns of proteins such as mu-opioid receptors and acetylcholinesterase, there are now over 60 genes known to be differentially expressed in patch vs. matrix compartments (Crittenden and Graybiel, 2011). Though patches only represent a small proportion of the striatum by volume, many of the differentially expressed genes are neuromodulators and their receptors suggesting that the patch and matrix have distinct pharmacological properties (Banghart et al, 2015; Brimblecombe and Cragg, 2016). Afferents to patch and matrix are also thought to arise from different sources with patches receiving limbic inputs and matrix neurons receiving sensorimotor inputs (Gerfen, 1984).…”
Section: General Overviewmentioning
confidence: 99%